Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set...( VENLO The Netherlands April 29 /-...),Health
| HOME >> MEDICINE >> TECHNOLOGY |
VENLO, The Netherlands, April 29 /PRNewswire-FirstCall/ -- QIAGEN N.V.
(Nasdaq: QGEN) today announced the Webcast of its first quarter 2008
financial results call. The Webcast will take place at 9:30 a.m. EDT on
Tuesday, May 6, and will include remarks by Peer M. Schatz, President and
Chief Executive Officer, and Roland Sackers, Chief Financial Officer.
What: Webcast of QIAGEN's first quarter 2008 financial results call
When: 9:30 a.m. EDT on May 6
Where: The Webcast is accessible at http://www.QIAGEN.com/goto/050608.
How: Log on to the Web at the address above.
The corresponding presentation slides are available for download in the investor relations section of QIAGEN's Web site at http://www.QIAGEN.com/goto/050608.
Contact: David Schull, Russo Partners, (212) 845-4271
QIAGEN N.V., a Netherlands holding company, is the leading provider of
sample and assay technologies. Sample technologies are used to isolate and
process DNA, RNA and proteins from biological samples such as blood or
tissue. Assay technologies are used to make such isolated biomolecules
visible. QIAGEN has developed and markets more than 500 consumable products
as well as automated solutions for such consumables. The company provides
its products to molecular diagnostics laboratories, academic researchers,
pharmaceutical and biotechnology companies, and applied testing customers
for purposes such as forensics, animal or food testing and pharmaceutical
process control. QIAGEN's assay technologies include what is considered to
be the broadest panel of molecular diagnostic tests avail
'/>"/>
| SOURCE QIAGEN N.V. Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
4. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
5. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |